Inhibition of presenilins attenuates proliferation and invasion in bladder cancer cells through multiple pathways (Q39158662)

9 September 2017

title

Inhibition of presenilins attenuates proliferation and invasion in bladder cancer cells through multiple pathways (English)

1 reference

9 September 2017

Jun-Wei Gai

1 reference

9 September 2017

Wasilijiang Wahafu

1 reference

9 September 2017

Ya-Ching Hsieh

1 reference

9 September 2017

Miao Liu

1 reference

9 September 2017

Liang Zhang

1 reference

9 September 2017

Sheng-Wen Li

1 reference

9 September 2017

Bei Zhang

1 reference

9 September 2017

Qun He

1 reference

9 September 2017

Hui Guo

1 reference

9 September 2017

Jie Jin

1 reference

9 September 2017

publication date

28 April 2013

1 reference

9 September 2017

1 reference

9 September 2017

1 reference

9 September 2017

1 reference

9 September 2017

page(s)

36.e19-25

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

9 September 2017

1 reference

Diagnosis and treatment of bladder cancer: how can we improve?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Molecular pathways of urothelial development and bladder tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Novel research horizons for presenilins and γ-secretases in cell biology and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Presenilins: members of the gamma-secretase quartets, but part-time soloists too.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

gamma-Secretase: a multifaceted regulator of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

&#947;-Secretase-Regulated Signaling Pathways, such as Notch Signaling, Mediate the Differentiation of Hematopoietic Stem Cells, Development of the Immune System, and Peripheral Immune Responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Inhibition of gamma-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Association of low expression of notch-1 and jagged-1 in human papillary bladder cancer and shorter survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Expression of the epidermal growth factor receptor family in normal and malignant urothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Expression of E-, P-, n-cadherins and catenins in human bladder carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

VEGF receptor expression and signaling in human bladder tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Presenilin 1 and cadherins: stabilization of cell-cell adhesion and proteolysis-dependent regulation of transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Gamma-secretase inhibitor treatment promotes VEGF-A-driven blood vessel growth and vascular leakage but disrupts neovascular perfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

Hallmarks of Cancer: The Next Generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.02.014

10.1016/J.UROLONC.2013.02.014

7 January 2021

Identifiers

DOI

1 reference

9 September 2017

1 reference